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Abstract
Background: Dissecting the genomic spectrum of clinical disease entities is a challenging task. Recursive
partitioning (or classification trees) methods provide powerful tools for exploring complex interplay among genomic
factors, with respect to a main factor, that can reveal hidden genomic patterns. To take confounding variables into
account, the partially linear tree-based regression (PLTR) model has been recently published. It combines regression
models and tree-based methodology. It is however computationally burdensome and not well suited for situations
for which a large number of exploratory variables is expected.
Methods: We developed a novel procedure that represents an alternative to the original PLTR procedure, and
considered different selection criteria. A simulation study with different scenarios has been performed to compare the
performances of the proposed procedure to the original PLTR strategy.
Results: The proposed procedure with a Bayesian Information Criterion (BIC) achieved good performances to detect
the hidden structure as compared to the original procedure. The novel procedure was used for analyzing patterns of
copy-number alterations in lung adenocarcinomas, with respect to Kirsten Rat Sarcoma Viral Oncogene Homolog
gene (KRAS) mutation status, while controlling for a cohort effect. Results highlight two subgroups of pure or nearly
pure wild-type KRAS tumors with particular copy-number alteration patterns.
Conclusions: The proposed procedure with a BIC criterion represents a powerful and practical alternative to the
original procedure. Our procedure performs well in a general framework and is simple to implement.
Keywords: Recursive partitioning, Tree-based regression, Lung cancer, Disease taxonomy, Genomic
Background
Recent advances in large-scale genomic technologies pro-
vide an unprecedented amount of data that offer new
insights into the molecular portraits of diseases. This
information enables to dissect a heterogeneous disease
entity into more homogeneous subentities that can be
relevant for clinical purposes.
This problem is particularly appealing in oncology
where molecular classification of tumors, that are based
on the status of specific targeted therapy, rely mainly
upon a single molecular event but overlook tumoral
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genomic complexity. For most solid epithelial tumors,
these genomic events are primarily DNA mutations that
give selective growth advantages to tumor cells.
A classical example in non-small-cell lung cancer
(NSCLC) is the activating EGFR (epidermal growth
factor receptor) mutation that predicts the sensitivity
to EGFR tyrosine kinase inhibitors. EGFR-mutant lung
adenocarcinoma is nowadays almost considered as a dis-
tinct disease entity. Such is not the case for KRAS (Kirsten
Rat Sarcoma Viral Oncogene Homolog gene) mutation
that represents one of the most common mutations in
NSCLC. With the exception of its well-known mutually
exclusive relationship with EGFR mutation, the clinical
utility of KRAS mutation status has not been clearly
demonstrated [1]. Moreover, it is still unclear whether
subgroups exist within KRAS wild-type or KRASmutated
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tumors. The identification ofmore homogeneousmolecu-
lar subgroups with respect to KRASmutational statusmay
provide new genomic taxonomy of NSCLC tumors, that
may help for the advancement of personalized medicine.
The aim of the clinical study that prompted this
methodological work was to decipher heterogeneity of
lung adenocarcinomas with respect to KRAS mutation
status based upon whole-genome copy-number alter-
ations. Copy-number alteration (CNA) is one of the main
type of genomic alterations that is linked to genome insta-
bility and represents a key feature of human carcinomas
[2]. In previous cancer studies, association between spe-
cific CNAs and point mutations have been reported such
as, for example, the relationship between EGFRmutations
and copy-gains of 7p12 (which harbors EGFR gene) in
lung adenocarcinomas. However, few investigations have
been performed for studying the relationships between
KRAS mutation and CNAs.
Identifying homogeneous subgroups, with respect to
a main factor, based on the complex interplay among
genomic alterations is a difficult task that cannot be easily
done with standard regression models.
In contrast, recursive partitioning (or tree-based)
methods such as CART (Classification And Regression
Tree) [3] is a flexible and powerful alternative for explor-
ing high-order interaction between explanatory variables.
From a data mining perspective, the purpose of such
approach is to decompose a data space recursively into
smaller areas that are defined by the set of explanatory
variables and tree-structured. The hypothesis space is the
set of all possible hyper-rectangular areas. These areas
are more homogeneous with respect to the main fac-
tor as compared to the whole population. The analysis
of the patterns of these areas, that are defined by the
explanatory variables, can provide meaningful biologi-
cal insights. In the context of non-parametric statistical
methods, random forests [4] is the classical extension
to tree-based methods with many available R packages
(for a few: VarSelRF [5], SRF [6], RF [7]). As compared
to tree-based methods, a forest that consists of thou-
sands of unpruned trees is more stable and well suited for
prediction. However, random forests loose the easy inter-
pretability of CART, which represents the key objective
when dissecting the clinico-biological spectrum of clinical
disease entities.
For clinical epidemiology studies, an important draw-
back of classical tree-based methodology is that it does
not provide a straightforward way of adjusting for con-
founding variables. In practice, confounding and explana-
tory variables are considered in the same way. Thus, the
final tree is a mixture of confounder and explanatory
variables lacking of clear interpretation and whose joint
effects are distorted. This problem was of particular con-
cern in our clinical studies since our series was composed
of two different sub-populations (Asian and Caucasian
patients). In lung adenocarcinomas, KRAS mutation is
found in about one third of the tumours in Caucasian
populations, as opposed to less than one tenth is Asian
populations. Thus, in our study, it was mandatory to
adjust for this confounding factor.
In a pioneering a work, Chen et al. [8] have intro-
duced a new class of regression models, called partially
linear tree-based regression models (PLTR). This new
framework has been proposed for genetic epidemiology
studies in order to assess complex joint gene-gene and
gene-environment effects taking into account confound-
ing variables. In practice, PLTR models represent a new
class of semi-parametric regressionmodels that integrates
the advantages of generalized linear regression and tree-
structure models. The linear part is used to model the
main effects of confounder variables and the nonparamet-
ric tree part is used to capture the distributional shape
of the data relying on the complex joint effects of mul-
tiple explanatory variables. In their article, Chen et al.
have proposed a four-step selection and testing proce-
dure for identifying the optimal tree while adjusting for
linear (on the generalized linear scale) confounding vari-
ables. This methodology has been recently extended for
considering multivariate outcomes [9]. However, Chen’s
et al. procedure heavily relies on resampling, which is
computationally burdensome and not well-suited to situ-
ations for which a large number of explanatory variables
is expected. In the present work, we propose and evaluate
an alternative procedure with different selection criteria,
which considers separately the objectives of selection and
testing.
We first describe the novel procedure with three differ-
ent selection criteria. It corresponds to a modified PLTR
procedure with four steps, of which the two first are com-
mon to the one proposed by Chen et al. A simulation
study with different scenarios is presented that compares
the power of the proposed procedure to the original PLTR
strategy. The proposed procedure is used to decipher
heterogeneity of lung adenocarcinomas, with respect to
KRAS mutation, based on copy-number alterations.
Methods
In the following we present our novel procedure with
different selection criteria. The first two steps are simi-
lar to those of the original PLTR procedure (Chen et al.)
whereas the last two steps are new. The four steps
are summarized in Figure 1 and presented in details
below.
Denote Y the outcome of interest (or the main fac-
tor for the application considered in this work), X the
confounding variables (to be modeled linearly), and Z
the explanatory variables. The PLTR model is specified
by:
Mbogning et al. Journal of Clinical Bioinformatics 2014, 4:6 Page 3 of 11
http://www.jclinbioinformatics.com/content/4/1/6
Figure 1 Flow-chart of the four steps of the method.
g (E (Y|X,Z)) = X′θ + βTF (T (Z)) , (1)
where g(·) is a known link function (generalized linear
model), F (T (Z)) is a vector of indicator variables repre-
senting the leaves of the tree T (Z).
Step 1: Construction of a maximal tree
The maximal tree is constructed as follows:
• Initialization: fit the generalized linear model
(GLM) g (E (Y|X,Z)) = X′θ(0) + β(0)
• Iterations: iterate the following steps starting with
k = 1.
– fit the tree part: construct a maximal tree
model T (k) based on Z, using X′θ(k−1) as
offset
– fit the leaves of the tree: fit the GLM
g (E (Y|X,Z)) = β(k)T F
(
T (k) (Z)) using
X′θ(k−1) as offset
– fit the parametric part: fit the GLM
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• Ending conditions: the algorithm stops when the
estimates of θ stabilize within a pre-specified range or
after a pre-specified number of iterations.
In the above procedure, an offset is a predictor variable
included in the model with coefficient fixed equal to one.
In the construction of the tree, the goodness of a can-
didate split is assessed for each node by the deviance of a
generalized linear model fitted in the node by considering
X′θ as the offset. More precisely, the goodness of a candi-
date split is the deviance of the parent nodeminus the sum
of the deviance of the two child nodes. The recursive par-
titioning stops when the number of cases in each terminal
node is smaller than a pre-assigned threshold.
Step 2: Construction of the sequence of nested subtrees
At the end of the previous step, the estimated tree TR
is a maximal tree which generally overfits the data. The
second step constructs a sequence of nested subtrees of
TR.
The PLTR model (1) obtained from the previous step is
g (E (Y|X,Z)) = X′θˆTR + βˆTRF (TR (Z)) , (2)
where TR (Z) represents the maximal tree at convergence,





be the deviance computed under the null
hypothesis





the deviance computed under the
alternative hypothesis
H1 : g (E (Y|X,Z)) = X′θ + βTF (T (Z)) , (4)
with a tree T(Z) ⊆ TR(Z).
Let r ≤ R be the pre-specified maximal size of subtrees
to be considered. A sequence of nested candidates sub-
trees T2(Z) ⊂ · · · ⊂ Tr(Z) of TR(Z) is constructed as
follows:
• The procedure is forward with T1(Z) representing
the root of the tree TR(Z). Let{
Tmj (Z), m = 1, . . . , nj
}
be the set of subtrees of
TR(Z) with j leaves, such that for allm = 1, . . . , nj,
Tj−1 is a subtree of Tmj : Tj−1 (Z) ⊂ Tmj (Z).• Tj (Z) is the subtree of TR(Z) with j leaves such that
Tj−1 (Z) ⊂ Tj (Z), chosen as Tj = Tm∗j with









X,Tmj (Z) ; θˆTmj
)]
.
Step 3: tree selection
We select one of the trees of the sequence T1 ⊂ T2 ⊂
· · · ⊂ Tr . For this selection step, we use either
• penalized maximum likelihood methods: the Akaïke
information criterion(AIC) [10] and the Bayesian
information criterion (BIC) [11],
• or a cross-validation method.
The competing models to be considered are:




, j = 1, . . . , r
(5)
with F (T1 (Z)) ≡ 1 representing the situation where the
tree is reduced to the root node, that is the null model (3).
BIC and AIC criteria









− δj log (N) ,
N being the sample size, δj the number of free param-





the log-likelihood for the model M̂j.
The model selected by the BIC criterion is M̂bic =
M̂j bic , where j bic is defined by






We denote Tbic = Tjbic the tree used in the model M̂bic.










with δj = dim (θ) + j. The model selected by the AIC
criterion is M̂aic = M̂j aic where j aic is defined by






We denote Taic = Tj aic the tree used in the model M̂aic.
Cross-validation criterion
As an alternative to the penalized maximum likelihood
criteria presented above, we propose a cross-validation
procedure on the global PLTR model for selecting the
optimal tree. The competing models M̂j are those defined
in (5).





A, withA ∩Am = ∅ for all  
= m
For  = 1, . . . ,K , denotes by A− = ⋃m 
=Am the th
training set, whileA is the corresponding validation set.
For each  = 1, . . . ,K , the following steps are per-
formed:
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• fit the PLTR model (1) with the sampleA−. At the
end of step 1, the fitted PLTR model is





where TR (Z) represents the maximal tree at
convergence.
• Construct a sequence of r − 1 nested subtrees
T2 (Z) , . . . ,Tr (Z) as in step 2, and determine the
underlying PLTR models sequence:




, j=1, . . . , r
• For each j = 1, . . . , r, use the validation sampleA to
compute the cross-validation error CV j of the model
M̂j .





The selected model is M̂cv = M̂j cv where j cv is defined
by
j cv = arg min
j=1,...,rCVj.
We denote Tcv = Tjcv the tree used in the model M̂cv.
Step 4: Testing
To test the null hypothesis (3) versus the alternative (4),










As the model M̂H1 is not obtained as a maximum like-
lihood estimate, this statistic does not follow the “naïve”
χ2(j − 1) distribution where j is the number of leaves of
the tree used in M̂H1 . Fan et al. [12] demonstrated that for
a variety of models involving non parametric estimators,
such generalized likelihood ratio statistics follow a scaled
chi-squared distribution. In our case, this implies that for a
defined number of leaves j the distribution of is a scaled
chi-squared distribution:
m ∼ χ2(b). (6)
As the theoretical determination of m and b is cumber-
some, Fan et al. propose to simulate the null distribution
for estimating the constants m and b. In the following,
we use the conditional parametric bootstrap procedure
described below:
• Generate a new outcome Yb from the fitted model
g (E (Y|X)) = X′θˆ0 + βˆ0
• Fit the complete model (2) with Yb as the outcome











• Repeat the previous step until the size R is greater
than j
• Construct a sequence of candidate optimal subtrees{
Tbk ; k = 2, . . . , j
}










• Repeat this process B times
• Estimate b and m from the empirical moments of
sample 1, . . . ,B.
Once b and m have been estimated, a p-value is calcu-




A simulation study with a binary outcome (logit link) was
conducted to evaluate and compare the performances of
the proposed procedure (with the three selection criteria)
to the original one proposed by Chen et al.
We have considered three different scenarios for which
we used PLTR logistic model similar to the one considered
in Chen et al.
• In scenario 1, we simulated four Bernoulli variables
G1, G2, G3, G4 with probabilities 0.3, 0.25, 0.18 and
0.22 respectively, and an outcome Bernoulli variable,
denoted Y, according to the following model (null
hypothesis):
logitP (Y = 1|G1,G2,G3,G4) =β1 + θG1
with β1 = log(0.61), θ = log(2). Here G1 is the
confounding variable and G2, G3, G4 are the
explanatory variables.
• In scenario 2, we introduced ten additional Bernoulli
variables G5, . . . ,G14 with probabilities p = 0.5. The
Bernoulli variable Y is simulated according to the
following model:
logitP (Y = 1|G1, . . . ,G14) =β1+θG1 + β21G2=1,G3=0
+ β31G3=1,G4=0
+ β41G3=1,G4=1.
with β1 = log(0.45), θ = log(2), β2 = log(3.5),
β3 = log(2) and β4 = log(4.5). This scenario mimics
joint effects of G2, G3, and G4. The corresponding
tree is displayed in Figure (2). The variables
G5, . . . ,G14 are noise variables unrelated to Y.
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Figure 2 Tree used for scenario 2 simulations. The leaves are represented by circles and the number beneath each node represents the real
value of the coefficient consider in each leaf of the tree.
• In scenario 3, we considered a deeper tree with
non-independent explanatory variables G2, . . . ,G5.
The model is:





with β1 = log(1.8), θ = log(1.35), β2 = log(1.50),
β3 = log(2), β4 = log(0.36), β5 = log(2.5) and
β6 = log(0.36). The corresponding tree is displayed
in Figure (3).
The Bernoulli variables G1, . . . ,G5 were generated
from the following hierarchical model:
G0 ∼ B(0.2), logitP(Gi = 1) = logit(0.2) + G0
for i = 2, . . . , 5
and
logitP(G1 = 1) = logit (0.2) + log(2)G0.
Hence the variables G1, . . . ,G5 are marginally
dependent. The variables G6, . . . ,G15 are considered
as noise variables and are generated independently
from a Bernoulli distribution with p = 0.5.
For all scenarios the sample was set to n = 2000, and 300
datasets were simulated.
Simulation results
Figures 4 and 5 display the quantile-quantile plots of the
observed statistics for the “naïve” theoretical χ2 distribu-
tion with degrees of freedom equal to the number of leaves
minus 1, and for the scaled χ2 distribution (equation 6).
These figures show that the naïve distribution is inade-
quate; in contrast, the scaled distribution with estimated
m and b fits well the empirical distribution.
Figure 3 Tree used for scenario 3 simulations. The leaves are represented by circles and the number beneath each node represents the real
value of the coefficient consider in each leaf of the tree.
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Figure 4 Quantile-quantile plots of the observed statistics versus the “naïve” χ2 quantiles.
We assess whether or not the trees selected by step 3
in the sequence of nested trees have the correct num-
ber of leaves. Under scenario 1 (null hypothesis), a root
tree (one leaf ) is expected. As seen in Table 1, the proce-
dure with the BIC criterion (BIC) selects the root tree for
98.3% of the simulations, whereas the Chen et al. proce-
dure (named BOOT hereafter) succeeds for only 91% of
the simulations. For the 10-fold cross validation procedure
(CV), this proportion goes down to 84%, and for the AIC
criterion (AIC) it is only 47.3%.
Under scenario 2, the correct number is of 4 leaves.
As seen from Table 2, BIC has the best performance
with 44.3% of selected trees with four leaves. Moreover, it
exhibits the smallest dispersion around the target value.
In contrast BOOT selects a tree with only 2 leaves for all
the simulations. The performances of CV are inferior to
those from BIC, and the dispersion is higher. Finally, AIC
selects always trees with too many leaves. Similar results
are obtained with scenario 3 (where the correct number of
leaves is 6), with increased quality of CV (Table 3).
For the more complex scenario (scenario 3), we com-
puted the ten-fold cross-validation generalization error
for each of the 300 simulated data sets for BIC, AIC and
CV criteria. The distribution of the generalization errors
are displayed in Figure 6. CV and BIC have very similar
errors, while AIC have a slightly increased error.
In summary, the procedure using the BIC criterion
consistently outperforms the other procedures.
We also investigated which variables are present in the
splits of the trees selected by BIC under scenario 2 and 3
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Figure 5 Quantile-quantile plots of the observed statistics versus the scaled χ2 quantiles.
(Tables 4 and 5). For scenario 2, the so-called correct vari-
ables are G2 to G4, and in scenario 3, G2 to G5. In both
scenarios, we refer as incorrect variables the ten noise
variables. Under scenario 2, in 18% of the selected trees,
at least one noise variable appears; however, all three cor-
rect variables are present in 44.3% of the selected trees. In
all cases, at least two correct variables were selected. The
BIC procedure behaves better under scenario 3, withmore
Table 1 Number of trees by number of leaves, for the 300
trees selected by the different methods under scenario 1
Leaves 1 2 3 4 5 6
BOOT 273 8 8 7 1 3
CV 252 0 18 10 10 10
BIC 295 4 1 0 0 0
AIC 142 64 54 30 5 5
than 99% of trees involving all four correct variables, while
noise variables appear in 20% of the trees.
Analysis of lung adenocarcinomas
Description of the data
The dataset considered in this study is based on a French-
Singaporean study (Merlion study) of 230 patients with
lung adenocarcinomas [13]. The Western-Europe series
Table 2 Number of trees by number of leaves, for the 300
trees selected by the different methods under scenario 2
Leaves 1 2 3 4 5 6 7 8 9 10
BOOT 0 300 0 0 0 0 0 0 0 0
CV 0 18 83 61 36 32 21 19 13 17
BIC 0 0 112 133 46 7 2 0 0 0
AIC 0 0 0 0 0 0 3 8 24 265
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Table 3 Number of trees by number of leaves, for the 300
trees selected by the different methods under scenario 3
Leaves 1 2 3 4 5 6 7 8 9 10
BOOT 0 300 0 0 0 0 0 0 0 0
CV 0 0 41 16 22 154 22 12 17 16
BIC 0 0 0 1 89 162 36 9 3 0
AIC 0 0 0 0 0 0 0 1 2 297
(WE) included 139 tumors and the East-Asian series (EA)
included 91 tumors. Clinical characteristics were detailed
in a previous published article [13]. DNA was extracted
using standard protocols and stored at −80°C until use.
Copy number information was issued from Affymetrix
Genome-Wide Human SNP 6.0 arrays. Inferences about
the copy number status of each genomic segment (copy
loss, copymodal, copy gain) were obtained using themod-
ified CGHmix classification procedure [14]. In order to
summarize genomic information while keeping a suffi-
cient level of resolution, copy number status was aver-
aged (median estimate) over the 284 main cytogenetic
bands. Information about KRAS mutation was extracted
from the targeted mutation profiling performed using the
Sequenom Massarray 4 platform (Sequenom, San Diego,
CA). Here, the KRAS mutation status was defined as the
presence or absence of any mutation within KRAS gene.
In this dataset, we detected 54 KRAS mutations with 44
cases (31.6%) from the WE series and 10 cases (10.9%)
from the EA series.
We compared the results obtained from the Chen et al.
procedure [8] to those obtained by the novel procedure
with the BIC criterion. The “dependent” variable was the
KRAS mutation status (mutation/wild-type). The cohort
status (WE/EA) was the confounding binary variable. The
284 copy-number alterations (trinomial variable: copy-
loss, modal, copy gain) were considered as candidate


















Figure 6 Distribution of the generalization 10-fold
cross-validation error for AIC, BIC, CV criteria across the 300
simulated data sets.
Table 4 Variables selected by the procedure using BIC
criterion under scenario 2, with global percentages
between brackets
Incorrect variables
0 1 2 3 4 5
Correct 0 0 0 0 0 0 0
Variables 1 0 0 0 0 0 0
2 134 (44.66%) 22 (7.33%) 10 (3.33%) 0 0 1 (0.33%)
3 112 (37.33%) 19 (6.33%) 2 (0.66%) 0 0 0
soon as the number of cases in each terminal node was
below fifteen.
Results
The iterative procedure converged after 15 iterations. The
trees selected by Chen’s et al. method and by our pro-
cedure with the BIC criterion are displayed in Figure 7.
Chen’s et al. procedure led to two leaves that sepa-
rated tumors with and without copy-loss of 3q23. The
global adjusted p-value associated with the selected tree
is 0.0055. This model is a simple cohort-adjusted logis-
tic regression model with 3q23 copy-loss as the unique
explanatory variable.
Our procedure with the BIC criterion led to seven
leaves. We identified:
(i) two pure or nearly pure wild-type KRAS leaves (with
53 tumors and only one KRAS mutation)
characterized by no 3q23 copy-loss and a copy-loss
for either 9q12 or 3p11 cytoband,
(ii) a leave with a low rate of KRAS-mutated tumors (8%)
characterized by no copy-loss of 3q23, 3p11, 9q12,
14q23 but a copy gain of 8q23 cytoband,
(iii) a leave with a medium rate of KRAS-mutated tumor
(15.5%) with no copy-loss of 3q23, 3p11, 14q23 and
no copy-gain of 8q23 and 1q32 cytoband,
(iv) the three other leaves were heterogeneous with a
mixture of wild-type and KRAS-mutated tumors
(43.5%, 52.6%, 51.2%).
Table 5 Variables selected by the procedure using BIC
criterion under scenario 3, with global percentages
between brackets
Incorrect variables
0 1 2 3 4 5
Correct 0 0 0 0 0 0 0
variables 1 0 0 0 0 0 0
2 0 0 0 0 0 0
3 1 (0.33%) 1 (0.33%) 0 0 0 0
4 239 (79.66%) 50 (16.66%) 8 (2.66%) 1 (0.33%) 0 0
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Figure 7 Optimal tree obtained with the two competing methods on the real data set: (a) BIC selected tree, (b) Original PLTR selected
tree. The leaves are represented by circles and the number in each leave node represents the number of observations falling inside the node; the
percentage represented proportion of cases inside the node.
For the selected tree, the split variables are copy-number
aberrations of 1q32, 3p11, 3q23, 8q23, 9p12, and 14q23.
The global p-value associated with this tree is 0.011 with
a ten-fold cross-validation generalization error of 0.23.
These results were obtained after adjustment for a signifi-
cant cohort effect (OR = 0.266, 95% Confidence interval:
[0.12−0.56]) with a higher rate of KRAS for theWE series
as compared to the EA series.
We also compared the characteristics of the 53 tumors
arising from the two pure or nearly pure wild-type KRAS
leaves as compared to the other tumors. There was no sig-
nificant difference between the two groups regarding the
EGFR mutation status (p = 0.94). There was a signifi-
cantly higher proportion of tumors with a large fraction of
genome altered (more than 50%) in the pure or nearly pure
wild-type KRAS group as compared to the other groups
(p = 1.7 × 10−8).
Discussion
Nowadays, there is a growing interest in deciphering
the genomic spectrum of clinical disease entities. In this
context, recursive partitioning methodology provides a
powerful data mining tool for exploring complex interplay
between genomic factors, with respect to a main factor,
that can reveal hidden genomic patterns. The requirement
of adjusting for confounding factors led Chen et al. to
develop a semiparametric regression model called PLTR
together with an iterative algorithm procedure to select
and test the “optimal” tree. A main drawback of the
procedure is that it relies on a two levels permutation
strategy which can become cumbersome and computa-
tionally expensive. In this work, we propose a novel pro-
cedure with different selection criteria. As shown from
the simulation study, the proposed procedure with the
BIC criterion achieves good power to detect the hidden
structure as compared to Chen’s et al procedure.
When investigating patterns of copy-number alterations
in lung adenocarcinomas, with respect to KRAS muta-
tion status and after adjustment for a cohort effect, our
proposed strategy highlights two subgroups of pure or
nearly pure wild-type KRAS tumors. These subgroups
correspond to 53 lung adenocarcinomas having no 3q23
copy-loss but copy-loss for either 9p12 or 3p11 cytoband.
It is worth noting that the 3q23 area harbors the PI3KCB
gene that participates in the PI3K (Phosphatidylinositol
3-kinase) signaling pathway, well-known to be deregulated
in many human cancers. Moreover, PI3K is one of the
main effector pathways of RAS, regulating cell growth, cell
cycle and cell survival. These wild-type KRAS subgroups
are not enriched for EGFR mutation (mutually exclusive
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with KRAS mutation) and are composed of tumors hav-
ing a proportion of copy-number changes significantly
higher than expected by chance. The genomic patterns
of these two wild-type KRAS subgroup are worth further
investigation.
Conclusion
We have proposed a novel recursive partitioning proce-
dure for deciphering the genomic spectrum of clinical
disease entities. The proposed procedure represents a
powerful and practical alternative to the partially linear
tree-based regression model proposed by Chen et al. [8].
Our procedure performs well, is simple to implement, less
computationally demanding and can be recommended
for investigating new disease taxonomy. The procedure
is implemented within an R package known under the
acronym ‘GPLTR’ and will be available very soon on the
CRAN site.
We plan to use this novel procedure to identify new
sub-groups of multiple sclerosis treated with interferon-
beta, with regards to the occurrence of antidrug-antibody
response, while adjusting for cohort effect.
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